MedTrace Logo

Preventing Lack of Iodine During Pregnancy

NCT00379535 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 374

Last updated 2011-10-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of potassium iodide during pregnancy on neuro-cognitive development of children followed up until two years.

Conditions

  • Pregnancy

Interventions

DRUG

potassium iodide

per os

DRUG

placebo

per os

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • CARON PHILIPPE, Pr · University Hospital, Toulouse

  • WEMEAU Jean-Louis, Pr · CHRU LILLE

  • NICCOLI-SIRE Patricia, Pr · CHU Timone MARSEILLE

  • BRUCKER-DAVIS Francoise, Dr · CHU NICE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2008-12-31
Completion
2010-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00379535 on ClinicalTrials.gov